DJIA 18,053.71 0.00 0.00%
NASDAQ 4,806.86 0.00 0.00%
S&P 500 2,086.84 -1.93 -0.09%
market minute promo

Express Scripts (NASDAQ: ESRX)

85.75 0.02 (0.02%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ESRX $85.77 0.04%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.74
Previous Close $85.74
Daily Range $85.21 - $86.27
52-Week Range $64.64 - $86.27
Market Cap $62.9B
P/E Ratio 34.19
Dividend (Yield) $0.00 (0.0%)
Volume 1,956,750
Average Daily Volume 3,951,830
Current FY EPS $4.88




Healthcare Information Services

Express Scripts (ESRX) Description

Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers. Website:

News & Commentary

Is Gilead Sciences, Inc. a Value Stock Following Its Tumble?

Gilead Sciences' slate of catalysts and a forward P/E of less than 10 make it intriguing.

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

Should AbbVie Inc. and Gilead Sciences, Inc. Fear This Biotech Instead of Each Other?

Achillion Pharmaceuticals ACH-3102 helps cure hepatitis C patients more quickly than Gilead Sciences and AbbVie.

First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases in Value by 35%

First Pacific Advisors' Third-Quarter Investment in Yahoo! Increases in Value by 35%

Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More

After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog

Could Express Scripts Holding Company's Gilead Gamble Backfire?

Express Scripts puts its foot down on Gilead Sciences' hepatitis C drug pricing. While the move looks like a no-brainer on the surface, could it actually come back to haunt Express Scripts?

First Week Of August 2015 Options Trading For Express Scripts Holding

What Happened To Gilead Is Health Reform In Action

See More ESRX News...

ESRX's Top Competitors

ESRX $85.75 (0.02%)
Current stock: ESRX
UNH $102.61 (0.06%)
Current stock: UNH
ANTM $126.40 (0.03%)
Current stock: ANTM
FMS $37.53 (0.75%)
Current stock: FMS